Continuous Renal Replacement Therapy Market by Adoption & Procedures, Modality (CVVH, SCUF, CVVHDF, CVVHD), Product (Disposables (Bloodlines & Hemofilters), Dialysate, Systems), and Region (Asia-Pacific, North America, Europe) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: May 28, 2019
Clear
SKU: GMS1174 Category:

The overall continuous renal replacement therapy (CRRT) market size is projected to reach USD 1.83 billion by 2024, growing at a CAGR of 6.87% over the forecast period. Increasing prevalence of AKI and renal disorders, increasing number of ICU patients, and CRRT’s clinical advantages over intermittent techniques of blood purification are some of the key factors that drive growth in this market.

Continuous Renal Replacement Therapy Market by Adoption & Procedures, Modality (CVVH, SCUF, CVVHDF, CVVHD), Product (Disposables (Bloodlines & Hemofilters), Dialysate, Systems), and Region (Asia-Pacific, North America, Europe) - 2019 to 2024 1

Continuous Renal Replacement Therapy Market by Adoption & Procedures, Modality (CVVH, SCUF, CVVHDF, CVVHD), Product (Disposables (Bloodlines & Hemofilters), Dialysate, Systems), and Region (Asia-Pacific, North America, Europe) - 2019 to 2024 2

Continuous Renal Replacement Therapy Market by Adoption & Procedures, Modality (CVVH, SCUF, CVVHDF, CVVHD), Product (Disposables (Bloodlines & Hemofilters), Dialysate, Systems), and Region (Asia-Pacific, North America, Europe) - 2019 to 2024 3

Continuous Renal Replacement Therapy Market by Adoption & Procedures, Modality (CVVH, SCUF, CVVHDF, CVVHD), Product (Disposables (Bloodlines & Hemofilters), Dialysate, Systems), and Region (Asia-Pacific, North America, Europe) - 2019 to 2024 4

Continuous Renal Replacement Therapy Market by Adoption & Procedures, Modality (CVVH, SCUF, CVVHDF, CVVHD), Product (Disposables (Bloodlines & Hemofilters), Dialysate, Systems), and Region (Asia-Pacific, North America, Europe) - 2019 to 2024 5

Continuous Renal Replacement Therapy Market by Adoption & Procedures, Modality (CVVH, SCUF, CVVHDF, CVVHD), Product (Disposables (Bloodlines & Hemofilters), Dialysate, Systems), and Region (Asia-Pacific, North America, Europe) - 2019 to 2024 6

Continuous Renal Replacement Therapy Market by Adoption & Procedures, Modality (CVVH, SCUF, CVVHDF, CVVHD), Product (Disposables (Bloodlines & Hemofilters), Dialysate, Systems), and Region (Asia-Pacific, North America, Europe) - 2019 to 2024 7

Continuous Renal Replacement Therapy Market by Adoption & Procedures, Modality (CVVH, SCUF, CVVHDF, CVVHD), Product (Disposables (Bloodlines & Hemofilters), Dialysate, Systems), and Region (Asia-Pacific, North America, Europe) - 2019 to 2024 8

1 Global Continuous Renal Replacement Therapy Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Continuous Renal Replacement Therapy Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Continuous Renal Replacement Therapy Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Continuous Renal Replacement Therapy Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Continuous Renal Replacement Therapy Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Continuous Renal Replacement Therapy Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Continuous Renal Replacement Therapy Market – By Modality (Market Size – & million/billion)
8.1 Continuous Venovenous Hemofiltration (CVVH)
8.2 Continuous Venovenous Hemodiafiltration (CVVHDF)
8.3 Continuous Venovenous Hemodialysis (CVVHD)
8.4 Slow Continuous Ultrafiltration (SCUF)

9 Global Continuous Renal Replacement Therapy Market – By Type
9.1 Dialysates and Replacement Fluids
9.2 Disposables
9.3 Hemofilters
9.4 Bloodline Sets
9.5 Other

10 Global Continuous Renal Replacement Therapy Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Continuous Renal Replacement Therapy Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Continuous Renal Replacement Therapy Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Baxter International Inc.
12.3 B. Braun Melsungen AG
12.4 Asahi Kasei Medical Co., Ltd.
12.5 Fresenius Medical Care AG & Co. KGaA
12.6 Nikkiso Co., Ltd.
12.7 Nxstage Medical, Inc.
12.8 BeLLCo S.R.L. (A Part of Medtronic PLC)
12.9 Medica S.P.A.
12.10 Toray Medical Co., Ltd.
12.11 Infomed Sa
12.12 Company 11 & more

13 Global Continuous Renal Replacement Therapy Market – Appendix
13.1 Sources
13.2 Abbreviations